METAMARK GENETICS

metamark-genetics-logo

Metamark Genetics, Inc is a life science company dedicated to the development of prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients, improved outcomes, and reduced healthcare costs. Metamark was founded in November, 2007 to transform cancer diagnosis and treatment by developing pioneering diagnostic products based on its Prognosis Determinantsâ„¢ Platform. Prognosis Determinantsâ„¢ are functionally validated genetic elements... at the core of cancer progression across many major cancer types. Based on pioneering research in melanoma by Dr. Lynda Chin at the Dana-Farber Cancer Institute and Harvard Medical School, the Prognosis Determinantsâ„¢ were first discovered as functionally active drivers of metastasis that confer poor outcome. Prognosis Determinantsâ„¢ have been shown to be relevant to a broad spectrum of different tumors and can stratify patients according to their overall and metastasis-free survival.

#SimilarOrganizations #People #Financial #Website #More

METAMARK GENETICS

Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical Personal Health

Founded:
2007-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.metamarkgenetics.com

Total Employee:
51+

Status:
Active

Contact:
617-583-1400

Email Addresses:
[email protected]

Total Funding:
46.76 M USD

Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail JsDelivr ASP.NET IIS IIS 10 Lorem Ipsum Google DNS


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

collabrx-logo

CollabRx

CollabRx uses information technology to provide personalized cancer treatment planning services to cancer patients.

foundation-medicine-logo

Foundation Medicine

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

genes2me-p-limited-logo

Genes2me (P) Limited

Personalised Diagnostics: Mother & Child, D2C Genetic profiling, Oncology. IVD Manufacturing & POC RTPCR Molecular device solutions.

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

illumina-logo

Illumina

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

intarcia-therapeutics-logo

Intarcia Therapeutics

Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.

metabolistics-logo

Metabolistics

Metabolistics uses urine based lab tests for early breast and ovarian cancer detection.

mng-laboratories-logo

MNG Laboratories

MNG is your source for Neurogenetic Answers with a reputation for going beyond the expected to make a difference for patient care.

rosetta-genomics-logo

Rosetta Genomics

Rosetta Genomics discovers, develops and commercializes diagnostic tests for personalized medicine.

ruby-consulting-group-logo

Ruby Consulting Group

Marketing, Commercialization and Medical Diligence Services for Genetics, Genomics and Health-tech Companies


Current Advisors List

norman-selby_image

Norman Selby Member of Board of Directors @ Metamark Genetics
Board_member

Current Employees Featured

ronald-a-depinho_image

Ronald A. DePinho
Ronald A. DePinho Founder @ Metamark Genetics
Founder

david-cordo_image

David Cordo
David Cordo CFO @ Metamark Genetics
CFO

lynda-chin_image

Lynda Chin
Lynda Chin Founder @ Metamark Genetics
Founder

not_available_image

Anjen Chenn
Anjen Chenn Senior Vice President @ Metamark Genetics
Senior Vice President
2014-11-01

Founder


david-rimm_image

David Rimm

kenneth-e-weg_image

Kenneth E. Weg

lynda-chin_image

Lynda Chin

ronald-a-depinho_image

Ronald A. DePinho

Investors List

perseus_image

Perseus

Perseus investment in Series B - Metamark Genetics

Official Site Inspections

http://www.metamarkgenetics.com Semrush global rank: 10.05 M Semrush visits lastest month: 57

  • Host name: 146.88.104.161
  • IP address: 146.88.104.161
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Metamark Genetics"

Metamark Genetics - Crunchbase Company Profile & Funding

Metamark Genetics, Inc is a life science company dedicated to the development of prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients, …See details»

Metamark Genetics - PitchBook

Developer of advanced proteomics platform designed to address the complete diagnostic and therapeutic journey of a prostate cancer patient.See details»

Metamark Company Profile - Craft

Metamark Genetics is a company specializing in urological cancer care. It provides diagnostic and prognostic testing as well as clinical proteomics, the study of proteins and protein signatures …See details»

Metamark Genetics, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Metamark Genetics, Inc. with its drug pipeline, therapeutic area, technology platform, 5 news, and 4 literature.See details»

Metamark Genetics Inc - Company Profile and News

Metamark Genetics, Inc. operates as a biotechnology company. The Company develops function-based, prognostic and diagnostic tests focusing on enhancing cancer care.See details»

Metamark Genetics, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Metamark Genetics, Inc. of Beltsville, MD. Get the latest business insights from Dun & Bradstreet.See details»

Metamark Genetics - Products, Competitors, Financials, Employees ...

Metamark Genetics is a privately-held biotechnology company founded to develop novel, function-based prognostic and diagnostic tests aimed at improving urological cancer care. Use the CB …See details»

Metamark Genetics - LinkedIn

Since it’s founding in 2007 by world leaders in cancer biology, molecular diagnostics and personalized medicine, Metamark has evolved into a leader in clinical proteomics – the study …See details»

Metamark Genetics Company Profile: , Investments, Contact …

Metamark is a leader in the diagnosis and management of prostate cancer, cancer of the bladder and other urologic conditions. For more information, please visit the Metamark website at …See details»

Metamark Genetics - VentureRadar

Metamark is a privately held oncology company focused on the development of molecular function-based prognostic assays for early staged cancers. The... ... Find out more about …See details»

Metamark Genetics - Contacts, Employees, Board Members

Metamark Genetics develops prognostic and predictive diagnostic tests that enable personalized treatment planning for cancer patients.See details»

Metamark - Overview, News & Similar companies | ZoomInfo.com

Metamark contact info: Phone number: (877) 744-7781 Website: www.metamarkgenetics.com What does Metamark do? Metamark Laboratories Inc is a company that operates in the …See details»

Metamark Genetics, Inc. Completes $22 Million Series B Financing …

Jul 13, 2010 · Metamark's Prognosis Determinantsâ„¢ platform has illuminated the genetic drivers governing the lethal metastatic progression of major cancers and is now focused on pivotal …See details»

Making their Metamark - Drug Discovery News

Feb 10, 2012 · Metamark Genetics to provide novel cancer therapeutic targets to Janssen BiotechSee details»

Metamark Genetics, Inc. Completes $22 Million Series B ... - BioSpace

CAMBRIDGE, Mass., July 13 /PRNewswire/ -- Metamark Genetics, Inc., a molecular diagnostics company addressing a major challenge in cancer medicine, has completed a $22 million …See details»

Metamark Genetics, Inc. Completes $22 Million Series B Financing

Jul 14, 2010 · Metamark's Prognosis Determinants TM platform has illuminated the genetic drivers governing the lethal metastatic progression of major cancers and is now focused on …See details»

Metamark Genetics Completes $13 Million Series B Financing; …

Nov 6, 2012 · Metamark Genetics, Inc., a privately held, oncology-focused molecular diagnostics company, announced today that it has closed a $13 million series B financing led by current …See details»

linkstock.net © 2022. All rights reserved